Medicare audits can lead to severe financial penalties and compliance risks for healthcare providers. Without expert legal representation, your practice may face unwarranted sanctions or worse. At Health Law Alliance, we specialize in defending healthcare providers during Medicare audits. Our experienced team helps you navigate the audit process, mitigate risks, and defend your reputation.
As Seen On
.png)
Healthcare Specialty Attorneys and Consultants - Health Law Alliance specializes in healthcare law and is dedicated to defending healthcare providers and their licenses from overreach.
Tenacious Defense - Health Law Alliance has gone after – and beaten – much bigger opponents. When faced with a seemingly daunting legal issue, our attorneys are the ones to call.
Proven Track Record - The attorneys at Health Law Alliance have a demonstrated track record of success against the most aggressive government regulators and industry behemoths.
Frequently Asked Questions About Medicare Audits
Do Medicare audits target specific business types?
Medicare auditors often unfairly focus on independent providers versus larger health systems. But all provider types must contend with aggressive Medicare audits. Having experienced legal advocates levels the playing field.
Can your guidance help prevent future unfair targeting by Medicare audits?
Absolutely. We provide tailored Medicare audit compliance recommendations so providers can reinforce areas prone to Medicare audit scrutiny. Proper documentation is critical to rebutting Medicare audit allegations.
Will filing Medicare appeals or settlements impact my network contracts?
Retaliation for exercising Medicare audit appeal rights is prohibited. We incorporate proper legal protections into Medicare audit responses and settlements. Maintaining existing contracts is always a priority.
What recourse exists if advance Medicare audit notice isn't provided?
Lack of 30-day written Medicare audit notice violates statute in many states. We leverage penalties around insufficient Medicare audit notice periods into negotiation leverage.
Can you help if my license or network participation is jeopardized by a Medicare audit?
Yes. We ensure that Medicare audit sanctions comply with applicable federal and state laws. Medicare auditors are prohibited from acting in bad faith or arbitrarily under applicable law and Medicare audit manuals.
What are the costs of legal representation for Medicare audits?
We offer flexible fee arrangements based on the scope of Medicare audit representation required and Medicare audit stage. The earlier we are involved the better, as we can shape and limit Medicare audit scope, making legal representation more effective and less costly.
Speak to an experienced attorney today at no-cost to evaluate your situation and discuss how we can help.
Legal challenges can be complex and stressful. Our experienced attorneys are dedicated to offering personalized guidance and effective solutions to help you navigate your legal journey with confidence
CVS Caremark one of the three major PBMs that control nearly 90% of the market for prescription claims processing.
Learn More
Optum is one of three major PBMs that control nearly 90% of the market for prescription claims processing.
Learn More
ESI is one of the three major PBMs that control nearly 90% of the market for prescription claims processing.
Learn More
Prime has a relationship with ESI that provides for joint provider networks and oversight by both companies.
Learn More
Medicare and Medicaid use agencies like OIG or OMIG and outside contractors to audit prescription drug claims.
Learn More
Humana is a payor that uses PBMs and other contractors to audit government and commercial drug claims.
Learn More
Qlarant is contracted with Medicare to perform fraud, waste, and abuse audits and investigations.
Learn More
Safeguard is contracted with Medicare to perform fraud, waste, and abuse audits and investigations.
Learn More
To design an effective PBM audit response strategy, providers must understand the chain of events both prior to the initiation of a PBM audit and afterwards. For example, Special Investigative Units (SIUs) are often the genesis of a pharmacy audit, and the presence or absence of "audit risk factors" is informative on potentially broader exposure beyond the claims under audit. Any decision to resolve an audit should be informed and result in a full and final settlement of all liability, but PBM audit settlements need to be structured carefully to achieve this goal.
CVS Caremark, OptumRx, and Express Scripts, control at least 80% of the market, making them the three biggest PBMs. Humana also ranks among the largest. In addition, these PBMs regulate access to networks for smaller competitors, such as ESI's partnership with Prime. Plan sponsors, such as United Health, Cigna and Aetna, are vertically integrated with these PBMs, increasing audit risk for pharmacies because network sanctions are more likely to affect a significant aspect of a pharmacy's business across both government and commercial claims.
PBMs and payors use artificial intelligence and data mining across medical and pharmacy claims to identify areas of potential inquiry. Among other areas, these inquiries typically involve high-reimbursing medicines, brand/generic substitution, inventory discrepancies, co-payment collection, prior authorization, and telehealth relations. Separately, DEA conducts audits and inspections for compliance to controlled substance regulations.
Common types of PBM audits include desk audits; on-site audits; invoice audits; and prescription audits. Irrespective of the type of PBM audit, all interactions with PBMs should be taken extremely seriously and can lead to severe consequences if not handled appropriately. For example, there has been a sharp increase in the federal prosecution of pharmacists for audit-related conduct, including answering PBM questions incorrectly. Accordingly, pharmacies should consider using outside audit counsel to avoid these pitfalls.
Pharmacies can take various steps to prepare to meet PBM audits, including routine self-audits. In fact, the government publishes comprehensive guidance and a checklist to assist pharmacies in their audit planning, including self-audits around prescribing practices, controlled substance management, invoice management, and billing practices. If you need assistance designing or implementing an audit protection plan, please do not hesitate to contact us.
Defending against a PBM audit requires comprehensive knowledge of the rights, responsibilities, and intricacies of pharmacies and their laws and regulations. If your pharmacy has been identified for a PBM audit, there are a number of potential defenses available to you. The first defense against a PBM audit is to be proactive, and audit planning can lessen the chance of unfavorable findings. That said, it is often necessary to involve an attorney to hold PBMs to their obligations under law and provider agreements. For this reason, national audit services and pharmacy audit consultants are often ineffective.
Audit discrepancies and findings can be appealed based on the specific procedures outlined in the provider manuals. It is important to follow these requirements exactly, within the timeframes established, or your appeal rights could be lost and further review denied. In an appeal, it is critically important to make a complete record of why the audit findings or sanctions should be reversed, including through documentation, legal arguments, and corrective actions, if any. Depending on the outcome of the appeal, you may have further legal recourse against the PBM.
PBM audits can have severe repercussions depending on the results of the pharmacy audit, including recoupments, network sanctions, and criminal, civil and administrative investigations involving jail time, significant fines, and license revocation or exclusion. We publish a 10-part PBM Audit Guide that discusses the overlap between PBM audits and government investigations and how to successfully manage audit risk. This resource is complimentary to subscribers HERE.
%402x.svg){kind=icon}